News Website

Integrative transcriptomic analysis identifies shared EndMT-related gene signatures in endometriosis and recurrent miscarriage - Nature

Integrative transcriptomic analysis identifies shared EndMT-related gene signatures in endometriosis and recurrent miscarriage Nature

Published: Oct. 21, 2025, 9:39 a.m.

Read Full Article

Identification and Validation of Lactate-related gene signatures in endometriosis for clinical valuation and immune characterization by WGCNA and machine learning - Frontiers

Identification and Validation of Lactate-related gene signatures in endometriosis for clinical valuation and immune characterization by WGCNA and machine learning Frontiers

Published: Sept. 16, 2025, 6:06 p.m.

Read Full Article

Petition calling for statutory menstruation leave hits over 60,000 signatures - The New Feminist

Petition calling for statutory menstruation leave hits over 60,000 signatures The New Feminist

Published: Aug. 31, 2025, 2:49 a.m.

Read Full Article

A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma - Frontiers

A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma Frontiers

Published: Aug. 18, 2025, 5:24 p.m.

Read Full Article

Characterizing disease-associated microbiome signatures using matched... - researchgate.net

Characterizing disease-associated microbiome signatures using matched... researchgate.net

Published: July 17, 2025, 7:18 p.m.

Read Full Article

Schoolboy's bank holiday petition gains over 20,000 signatures - Yahoo

Schoolboy's bank holiday petition gains over 20,000 signatures Yahoo

Published: June 30, 2025, 3 p.m.

Read Full Article

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times

Published: Feb. 10, 2025, 2:34 p.m.

Read Full Article

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.

Read Full Article

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.

Read Full Article

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.

Read Full Article

Latest Articles

Integrative transcriptomic analysis identifies shared EndMT-related gene signatures in endometriosis and recurrent miscarriage - Nature

Identification and Validation of Lactate-related gene signatures in endometriosis for clinical valuation and immune characterization by WGCNA and machine learning - Frontiers

Petition calling for statutory menstruation leave hits over 60,000 signatures - The New Feminist

A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma - Frontiers

Characterizing disease-associated microbiome signatures using matched... - researchgate.net

Schoolboy's bank holiday petition gains over 20,000 signatures - Yahoo

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

Subscribe to Our Newsletter